All Stories

  1. Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?

    Article • Hepatic Medicine Evidence and Research, April 2015, Taylor & Francis

    Dr Sujit V Janardhan

  2. Primary Murine CD4+ T Cells Fail to Acquire the Ability to Produce Effector Cytokines When Active Ras Is Present during Th1/Th2 Differentiation

    Article • PLoS ONE, November 2014, PLOS

    Dr Sujit V Janardhan

  3. Evidence Implicating the Ras Pathway in Multiple CD28 Costimulatory Functions in CD4+ T Cells

    Article • PLoS ONE, September 2011, PLOS

    Dr Sujit V Janardhan, Professor Ralph A Tripp

  4. Erratum: T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-α

    Article • Nature Immunology, December 2006, Springer Science + Business Media

    Dr Sujit V Janardhan

  5. T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-α

    Article • Nature Immunology, October 2006, Springer Science + Business Media

    Dr Sujit V Janardhan

  6. Differential Ras signaling via the antigen receptor and IL-2 receptor in primary T lymphocytes

    Article • Biochemical and Biophysical Research Communications, December 2003, Elsevier

    Dr Sujit V Janardhan

  7. Water escape performance of adult RCS dystrophic and congenic rats: a functional and histomorphometric study

    Article • Brain Research, April 1996, Elsevier

    Dr Sujit V Janardhan